Latest

11:09
【iShares Core MSCI China Index ETF(02801.HK) Fell 1.58% to 24.960】Newtimespace News, as of 10:59 on May 18, iShares Core MSCI China Index ETF(02801.HK) fell 1.58% to HKD 24.960, with an asset size of approximately HKD 15.747 billion.
Tag： ETFiShares Core MSCI China Index ETF02801.HK
10:04
【CSOP Hang Seng Biotech ETF (03174.HK) Fell 2.11% to 3.240】Newtimespace News, as of 09:56 on May 18, CSOP Hang Seng Biotech ETF (03174.HK) fell 2.11% to HKD 3.240, with an asset size of approximately HKD 844 million.ETF
Tag： ETFCSOP Hang Seng Biotech ETF03174.HK
10:02
【Global X Hang Seng High Dividend Yield ETF (03110.HK) Fell 1.03% to 32.640】Newtimespace News, as of 09:56 on May 18, Global X Hang Seng High Dividend Yield ETF (03110.HK) fell 1.03% to HKD 32.640, with an asset size of approximately HKD 6.823 billion.
Tag： ETFGlobal X Hang Seng High Dividend Yield ETF03110.HK
10:00
【iShares Hang Seng TECH ETF (03067.HK) Fell 1.35% to 10.230】Newtimespace News, as of 09:56 on May 18, iShares Hang Seng TECH ETF (03067.HK) fell 1.35% to HKD 10.230, with an asset size of approximately HKD 15.468 billion.
Tag： ETFiShares Hang Seng TECH ETF03067.HK
09:54
【Csop Hang Seng Tech Index ETF(03033.HK) Fell 1.20% to 4.772】Newtimespace News, as of 09:51 on May 18, Csop Hang Seng Tech Index ETF(03033.HK) fell 1.20% to HKD 4.772, with an asset size of approximately HKD 84.595 billion.
Tag： ETFCSOP Hang Seng Tech Index ETF03033.HK
09:50
【Hang Seng China Enterprises Index ETF(02828.HK) Fell 0.83% to 88.360】Newtimespace News, as of 09:45 on May 18, Hang Seng China Enterprises Index ETF(02828.HK) fell 0.83% to HKD 88.360, with an asset size of approximately HKD 30.198 billion.
Tag： ETFHang Seng China Enterprises Index ETF02828.HK
09:45
【Tracker Fund Of Hong Kong(02800.HK) Fell 1.07% to 25.840】Newtimespace News, as of 09:40 on May 18, Tracker Fund Of Hong Kong(02800.HK) fell 1.07% to HKD 25.840, with an asset size of approximately HKD 136.437 billion.
Tag： ETFTracker Fund of Hong Kong
09:37
【CHINA XLX FERT(01866.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 299.64 million, YoY increase of 51.7%】NewTimeSpace News: May 15, 2026, CHINA XLX FERT(01866.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 6.82 billion, increased by 16.71% YoY
Tag： CHINA XLX FERT01866.HKprofit
09:33
【INFINITY DEV(00640.HK): FY 25/26 Interim Report - Profit Attributable to Shareholders stood at HKD 48.81 million, YoY decrease of 13.79%】NewTimeSpace News: May 15, 2026, INFINITY DEV(00640.HK) released its Interim Report for the period ended September 30, 2026, Total Revenue stood at HKD 401.54 million, decreased by 1.9% YoY
Tag： INFINITY DEV00640.HKfinancials
09:32
【QINGDA ORIENTAL(08115.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 7.27 million, YoY increase of 627.33%】NewTimeSpace News: May 15, 2026, QINGDA ORIENTAL(08115.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 62.45 million, increased by 220.94% YoY
Tag： QINGDA ORIENTAL08115.HKprofit growth
09:28
【ZHUGUANG HOLD(01176.HK): 2025 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 6.19 billion, loss widened by 81.33% YoY】NewTimeSpace News: May 15, 2026, ZHUGUANG HOLD(01176.HK) released its Annual Report for the period ended December 31, 2025, Total Revenue stood at HKD 1.39 billion, decreased by 12.3% YoY
Tag： ZHUGUANG HOLD01176.HKLoss widens
09:21
【Yidu Tech (02158.HK) Wins Full-hospital Data Center & Informatization Project in Fuling Chongqing, Worth Approximately RMB 9.65 Million】NewTimeSpace News: Yidu Tech Inc. (02158.HK) announced that its affiliate Yidu Cloud (Beijing) Technology Co., Ltd. has won the bid for the full-hospital data center and informatization project of Fuling Hospital Affiliated to Chongqing University, issued by Chongqing Digital Fuling Big Data Industry Development Co., Ltd., with a total project value of approximately RMB 9.6495 million.
Tag： YIDU TECH02158.HKwin the bid
09:16
【HBM HOLDINGS-B (02142.HK): Preclinical Data Unveiled for First AI-Derived Candidate LET003, Showing Remarkable Fat Loss & Muscle Preservation Combined with Semaglutide】NewTimeSpace News: Hbm Holdings Limited (02142.HK) announced preclinical research findings of LET003, its next-generation ACVR2A/2B-targeted monoclonal antibody developed via the Hu-mAtrIx™ AI platform. Data revealed that combination therapy of LET003 and semaglutide delivers markedly enhanced fat reduction and effective lean mass preservation. The combined group achieved a 34.7% greater reduction in fat mass and a 5.7% rise in lean mass compared with semaglutide monotherapy.
Tag： HBM HOLDINGS-B02142.HKpreclinical data
21:29
【Hong Kong's No.2 Beauty & Healthcare Retailer! Lung Fung Group Passes HKEX Listing Hearing】New Timespace News: Lung Fung Group Holdings Limited passed its HKEX listing hearing on May 17, with DBS Group as the sole sponsor. According to Frost & Sullivan, by retail sales value in 2024, the Group ranked second among beauty, healthcare and pharmaceutical retailers in Hong Kong with a 5.8% market share; it is also the largest pharmaceutical retailer in Hong Kong with a 5.2% market share. As of the latest practicable date, the company operates 31 retail stores under the "Lung Fung" brand in Hong Kong, along with various online sales platforms.
Tag： Lung Fung GroupIPOpass the listing hearing
21:21
【Zhongding Intelligent Refiles for HKEX Listing for Third Time, Holding 25.6% Market Share in New Energy Lithium Battery On-site Logistics】NewTimeSpace News: Zhongding Intelligent (Wuxi) Technology Co., Ltd. submitted its listing application to the Hong Kong Stock Exchange for the third time on May 15, with Guotai Junan International acting as the sole sponsor. According to Frost & Sullivan, based on 2025 revenue, the company ranks first in China’s intelligent on-site logistics solution market for new energy lithium-ion battery sector with a market share of 25.6%, second in China’s industrial intelligent on-site logistics sector with 3.2% share, and fourth across China’s overall intelligent on-site logistics solution industry with 1.6% share.
Tag： Zhongding IntelligentIPOrefile listing application
21:15
【Grace Fabric Technology Tops Global High-end Electronic Fabric Sector, Files for HKEX Listing】NewTimeSpace News: Grace Fabric Technology Co., Ltd. (603256.SH) submitted a listing application to the Hong Kong Stock Exchange on May 15, with CITIC Securities acting as the sole sponsor. According to Frost & Sullivan, the company ranks first globally by revenue of ultra-thin and super-thin electronic fabrics in 2025, commanding a market share of 20.5%. In the special electronic fabric segment, it ranks 3rd globally and 1st domestically in low CTE fabric revenue, and 7th globally and 3rd domestically in low Dk/Df fabric revenue. It is also one of only two domestic manufacturers capable of stable mass supply of second-generation low Dk/Df fabrics.
Tag： Grace FabricIPO603256.SHfile a listing application
21:06
【Guangdong Huacheng Electric Power Files for HKEX Listing, Holding Class A Licenses for Power Project Design & Consultancy】NewTimeSpace News: Guangdong Huacheng Electric Power Energy Co., Ltd. filed a listing application with HKEX on May 15, with Regal Corporate Finance Limited acting as the sole sponsor. According to Frost & Sullivan, it is one of only two private enterprises in Guangdong that hold both Class A licenses for power project design and consultancy. The company has delivered power design and project management services for landmark infrastructures including the Hong Kong-Zhuhai-Macao Bridge and Shenzhen-Zhongshan Link.
Tag： Huacheng ElectricIPOfile a listing application
20:41
【TRANSTHERA-B (02617.HK): Clinical Data of Core Product Tiengrtinib Published in Nature Communications】NewTimeSpace News: TransThera Sciences (Nanjing), Inc. (02617.HK) announced that exploratory clinical findings of its core product tiengrtinib as monotherapy and in combination with atezolizumab for advanced solid tumors have been published in Nature Communications (Impact Factor=15.7). Clinical data show that the objective response rate (ORR) of tiengrtinib monotherapy reached 16.7%, while the combination regimen achieved an ORR of 22.6%. It demonstrated prominent efficacy in cholangiocarcinoma patients, with an ORR of 30.8% under monotherapy.
Tag： TRANSTHERA-B02617.HKclinical development
20:31
【FAMEGLOW(08603.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 54.64 million, YoY increase of 19.49%】NewTimeSpace News: May 15, 2026, FAMEGLOW(08603.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 589.79 million, increased by 35.5% YoY
Tag： FAMEGLOW08603.HKprofit growth
20:30
【SUNLIGHT HLDGS(08451.HK): FY 25/26 Interim Report - Profit Attributable to Shareholders stood at SGD 468 thousand, YoY increase of 170.52%】NewTimeSpace News: May 15, 2026, SUNLIGHT HLDGS(08451.HK) released its Interim Report for the period ended September 30, 2026, Total Revenue stood at SGD 7.05 million, increased by 3.12% YoY
Tag： SUNLIGHT HLDGS08451.HKfinancials
Previous1..356357 358359360..488     488 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments